Seema A. Bhat, MD
Dr Seema Bhat explores how fixed-duration therapies are reshaping chronic lymphocytic leukemia (CLL) treatment, offering real-world insight into clinical decision-making, economic impact, and patient quality of life.
Dr Seema Bhat explores how fixed-duration therapies are reshaping chronic lymphocytic leukemia (CLL) treatment, offering real-world insight into clinical decision-making, economic impact, and patient quality of life.
Dr Seema Bhat explores how...